Řízení v oblasti veřejného zdraví EU

Improving health systems

Výchova k péči o zdraví

Medical devices

Substances of human origin

Krev, tkáně a orgány

Léčivé přípravky

Ochrana před nemocemi

Posuzování rizik

Vědecké výbory

Endocrine disruptors

Endocrine disruptors

Biocides

Biocides

Konzultace

Closed consultations

02 Květen - 02 Srpen 2018

Study supporting the Evaluation of the European Medicines Agency Fee System
20 Prosinec 2017 - 20 Březen 2018

Targeted stakeholders consultation on the revision of annex 1, on manufacturing of sterile medicinal products, of the Eudralex volume 4
27 Únor - 22 Květen 2017

Targeted stakeholder consultation on the revised guidelines on excipients in the labelling and package leaflet of medicinal products for human use
15 Listopad 2016 - 20 Únor 2017

Targeted stakeholder consultation on the experience acquired with the Paediatric Regulation
29 Červenec - 04 Listopad 2016

Public consultation on the concept of "similar medicinal product" in the context of the orphan legislation
28 Červen - 26 Září 2016

Targeted stakeholder consultation on the draft Guidelines on Good Manufacturing Practice for Advanced Therapy Medicinal Products
01 Červen - 31 Srpen 2016

Public consultation on "Risk proportionate approaches in clinical trials"
01 Červen - 31 Srpen 2016

Public consultation on "Summary of Clinical Trial Results for Laypersons"
01 Červen - 31 Srpen 2016

Public consultation on the revision of "Ethical Considerations for Clinical Trials on Medicinal products conducted with Minors"
01 Červen - 31 Srpen 2016

Public consultation on the revision of the "Definition of Investigational Medicinal Products (IMPs) and use of Auxiliary Medicinal Products (AMPs)"

Pages